Merit Medical Systems (MMSI) Expected to Announce Quarterly Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) is expected to release its Q4 2025 results after the market closes on Tuesday, February 24th. Analysts expect Merit Medical Systems to post earnings of $0.96 per share and revenue of $390.7730 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 4:30 PM ET.

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $81.66 on Tuesday. The company has a market cap of $4.84 billion, a P/E ratio of 41.88, a P/E/G ratio of 2.22 and a beta of 0.61. Merit Medical Systems has a twelve month low of $77.62 and a twelve month high of $110.10. The company’s 50-day moving average price is $84.53 and its 200-day moving average price is $85.10. The company has a current ratio of 4.28, a quick ratio of 2.86 and a debt-to-equity ratio of 0.48.

Insider Transactions at Merit Medical Systems

In other Merit Medical Systems news, Chairman Fred P. Lampropoulos sold 10,000 shares of Merit Medical Systems stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $88.04, for a total transaction of $880,400.00. Following the completion of the sale, the chairman directly owned 1,019,955 shares in the company, valued at $89,796,838.20. This trade represents a 0.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have sold 55,000 shares of company stock valued at $4,765,750. 3.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Merit Medical Systems

Hedge funds have recently made changes to their positions in the stock. Los Angeles Capital Management LLC acquired a new position in Merit Medical Systems during the fourth quarter worth $25,000. Danske Bank A S purchased a new stake in shares of Merit Medical Systems in the 3rd quarter valued at $42,000. Quarry LP lifted its stake in Merit Medical Systems by 185.9% during the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock worth $44,000 after acquiring an additional 342 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in Merit Medical Systems by 973.6% during the 4th quarter. Global Retirement Partners LLC now owns 569 shares of the medical instruments supplier’s stock valued at $50,000 after acquiring an additional 516 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in Merit Medical Systems by 745.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after acquiring an additional 813 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on MMSI shares. Piper Sandler restated an “overweight” rating and set a $109.00 target price (up from $105.00) on shares of Merit Medical Systems in a report on Friday, October 31st. Canaccord Genuity Group boosted their price objective on Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. BTIG Research assumed coverage on Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 target price for the company. Wells Fargo & Company lowered their price target on shares of Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, November 14th. Finally, Zacks Research cut shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Nine equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $106.00.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.